Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "GE"

9918 News Found

Dr. Mahesh N. Padamwar joins MSN Laboratories as Senior General Manager
People | June 11, 2026

Dr. Mahesh N. Padamwar joins MSN Laboratories as Senior General Manager

Pharmaceutical R&D veteran brings over 20 years of expertise in formulation development, ANDA filings, and regulated-market product innovation to strengthen MSN Laboratories’ global growth ambitions


AstraZeneca gets CDSCO nod for Trastuzumab Deruxtecan plus Pertuzumab
Drug Approval | June 11, 2026

AstraZeneca gets CDSCO nod for Trastuzumab Deruxtecan plus Pertuzumab

Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer


DePuy Synthes launches AI-powered hip surgery navigation system to streamline operating room workflow
News | June 10, 2026

DePuy Synthes launches AI-powered hip surgery navigation system to streamline operating room workflow

The company says the goal is to improve consistency and efficiency in total hip arthroplasty (THA) as demand for the procedure continues to surge


HAB Pharma targets Rs. 3,000 crore revenue by 2030
News | June 10, 2026

HAB Pharma targets Rs. 3,000 crore revenue by 2030

Consolidated entity plans to strengthen specialty pharmaceutical offerings, expand manufacturing capacity, and accelerate global market penetration across emerging regions


Ayushman Bharat achieves full national coverage as West Bengal gets onboard
Policy | June 09, 2026

Ayushman Bharat achieves full national coverage as West Bengal gets onboard

Nearly 1.43 crore families in West Bengal to benefit as India’s flagship health assurance scheme achieves full national coverage across all States and Union Territories


Pfizer reports strong mid-stage results for monthly GLP-1 drug berobenatide
News | June 09, 2026

Pfizer reports strong mid-stage results for monthly GLP-1 drug berobenatide

The company said data from multiple VESPER studies show the peptide delivered meaningful weight loss, favorable tolerability, and the possibility of a first-in-class monthly injection format


Eli Lilly's oral weight-loss drug shows major fat loss across stages of menopause in trials
Clinical Trials | June 09, 2026

Eli Lilly's oral weight-loss drug shows major fat loss across stages of menopause in trials

The results come from post-hoc analyses of more than 1,500 women enrolled in the Phase 3 ATTAIN-1 and ATTAIN-2 trials, presented at the American Diabetes Association’s 86th Scientific Sessions


FUJIFILM brings next-gen AI-enabled digital mammography platform to India
Medical Device | June 09, 2026

FUJIFILM brings next-gen AI-enabled digital mammography platform to India

First installation of AI-powered AMULET SOPHINITY at NM Medical aims to strengthen early breast cancer detection


Yashoda Medicity gets DGME approval for brain stem death certification committee
Hospitals | June 09, 2026

Yashoda Medicity gets DGME approval for brain stem death certification committee

The newly constituted committee will facilitate timely brain stem death certification, supporting transparent organ donation processes and expanding opportunities for patients awaiting transplants


Lilly’s “triple agonist” drug delivers striking weight loss & broad health gains in late-stage trials
News | June 09, 2026

Lilly’s “triple agonist” drug delivers striking weight loss & broad health gains in late-stage trials

Researchers say the results point to a potential shift in how obesity is treated—as a central disease driving multiple conditions, rather than a collection of separate problems